RELMADA THERAPEUTICS, INC.
Company Stats
- Market Cap
- $402.1M
- as of Sep 30, 2026
- Shares Outstanding
- 106.7M
- Free Float
- 94.4%
Income Statement
- Operating Income
- -$59.1M
- Net Income
- -$57.4M
Balance Sheet
- Cash & Equivalents
- $3.5M
Returns & Capital
- SBC, 3Y Avg
- $29.3M
Annual filing data through FY ended December 31, 2025; shares and float as of October 31, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
GameStop Insiders Bought $21.7 Million of Stock
Healthcare Earnings: Demand Surges, Costs Bite Back